AGM Result

RNS Number : 7872U

Allergy Therapeutics PLC

30 June 2009

 



Tuesday 30 June 2009

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Result of General Meeting

Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, is pleased to announce that at the General Meeting of the Company held today all of the resolutions were duly passed by shareholders. The proxy voting figures for the resolutions will be available in due course on the Company's website at http://www.allergytherapeutics.com/AGM.aspx

An application has been made for the 181,631,937 placing, subscription and offer shares of 0.1p each to be admitted to trading on AIM. It is expected that admission will become effective and dealings will commence at 08.00 am on 1 July 2009. 

Total Voting Rights Following Admission

After Admission of the placing, subscription and offer shares, the Company's issued voting share capital will consist of 263,998,551 ordinary shares of 0.1p each.

For further information

Allergy Therapeutics	[phone]
Keith Carter, Chief Executive
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw
Financial Dynamics	[phone]
Ben Brewerton/ Susan Quigley

 

END

 

 

AGMFMMMTMMAJBPL